Cardiff Oncology DSO Ratio | CRDF

Annual DSO Ratio Cardiff Oncology

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000
294	284	396	617	435	320	304	162	55.7	96.2	115	73.9	111	136	140	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
617	55.7	236

Quarterly DSO Ratio Cardiff Oncology

2026-Q2	2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
141	1.07 K	-	297	351	493	-	296	236	152	-	116	354	795	-	319	224	605	-	373	353	450	-	1.82 K	1.82 K	663	-	346	266	262	-	178	423	513	38	341	69	85.2	135	103	88.7	75.4	114	157	183	55.9	92.4	90.4	93	55.8	153	165	147	94.8	94.3	72.7	370	357	-	164	113	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.82 K	38	316

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AnaptysBio ANAB	205	$ 51.0	1.83 %	$ 1.48 B	USA
Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	5.06	-	-	$ 401 M	USA
BioMarin Pharmaceutical BMRN	88.9	$ 60.26	0.06 %	$ 11.6 B	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 2.17	0.46 %	$ 3.57 M	Israel
Genocea Biosciences GNCA	24.9	-	-15.0 %	$ 3.04 M	USA
Catalyst Biosciences CBIO	79.3	$ 13.99	0.84 %	$ 1.25 B	USA
C4 Therapeutics CCCC	27.9	$ 2.98	0.3 %	$ 247 M	USA
Codexis CDXS	30.9	$ 1.32	1.09 %	$ 115 M	USA
Cerus Corporation CERS	47	$ 2.62	0.38 %	$ 499 M	USA
G1 Therapeutics GTHX	52.6	-	-	$ 370 M	USA
Coherus BioSciences CHRS	559	$ 1.13	0.43 %	$ 132 M	USA
Celldex Therapeutics CLDX	321	$ 31.1	1.16 %	$ 2.07 B	USA
CollPlant Biotechnologies Ltd. CLGN	11.6	$ 4.25	3.16 %	$ 51.9 M	Israel
AbbVie ABBV	258	$ 264.34	0.09 %	$ 468 B	USA
Humanigen HGEN	598	-	-81.12 %	$ 4.28 M	USA
Cocrystal Pharma COCP	101	$ 1.17	1.74 %	$ 13.2 M	USA
AbCellera Biologics ABCL	173	$ 12.7	0.4 %	$ 3.79 B	Canada
Abeona Therapeutics ABEO	0.000094	$ 5.4	2.65 %	$ 286 M	USA
Collegium Pharmaceutical COLL	391	$ 22.53	0.2 %	$ 713 M	USA
Corcept Therapeutics Incorporated CORT	27.3	$ 116.1	4.93 %	$ 12.1 B	USA
Фармсинтез LIFE	209	-	-	-	Russia
IMV IMV	2.16 K	-	-	$ 13.1 M	Canada
Corbus Pharmaceuticals Holdings CRBP	239	$ 7.14	0.19 %	$ 95.1 M	USA
Karuna Therapeutics KRTX	15.9	-	-	$ 12.2 B	USA
Curis CRIS	64.7	$ 0.83	1.1 %	$ 10.9 M	USA
CorMedix CRMD	130	$ 7.85	1.03 %	$ 565 K	USA
Crinetics Pharmaceuticals CRNX	211	$ 84.95	0.13 %	$ 7.99 B	USA
CRISPR Therapeutics AG CRSP	1.3 K	$ 54.23	0.23 %	$ 4.88 B	Schweiz
Champions Oncology CSBR	74.9	$ 4.9	0.1 %	$ 67.8 M	USA
Chimerix CMRX	52.5	-	-	$ 756 M	USA
Cue Biopharma CUE	43.1	$ 31.41	1.45 %	$ 2.98 B	USA
CEL-SCI Corporation CVM	227	$ 1.67	2.38 %	$ 13.4 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.85	0.2 %	$ 929 M	Canada
Cytokinetics, Incorporated CYTK	71.3	$ 64.66	0.17 %	$ 7.77 M	USA
Daré Bioscience DARE	877	$ 0.78	4.73 %	$ 8.72 M	USA
Adagene ADAG	58.9	$ 2.93	2.86 %	$ 173 M	China
DiaMedica Therapeutics DMAC	569	$ 7.94	1.4 %	$ 373 M	USA